Rahmi Oklu MD, PhD (@rahmioklu) 's Twitter Profile
Rahmi Oklu MD, PhD

@rahmioklu

Professor, Physician, Scientist; Director, Laboratory for Patient Inspired Engineering— Tweets are my own.

ID: 1949889320

linkhttp://www.mayoclinic.org/biographies/oklu-rahmi-m-d-ph-d/bio-20236547# calendar_today09-10-2013 18:55:48

1,1K Tweet

2,2K Followers

303 Following

Rahmi Oklu MD, PhD (@rahmioklu) 's Twitter Profile Photo

Finally the day has come! Tuesday 9:55 AM in the Corporate Expo Theater at the Society of Interventional Radiology Meeting, Salt Lake City, Utah, clinical data on the Next Gen BPH and Liver Tumor Treatment will be presented. Stop by our expo booth #1331 #sir2024

Finally the day has come! Tuesday 9:55 AM in the Corporate Expo Theater at the Society of Interventional Radiology Meeting, Salt Lake City, Utah, clinical data on the Next Gen BPH and Liver Tumor Treatment will be presented. Stop by our expo booth #1331 #sir2024
Peter Pattison (@bsc_io) 's Twitter Profile Photo

At SIR #OBSIDIO #ConformableEmbolic completes LME demonstrating real-world technical success in a wide range of clinical applications including trauma which constituted roughly 1/3 of applications (45/131). Learn more about Obsidio: bit.ly/3PAwjFx bit.ly/3wnXYCT

Rahmi Oklu MD, PhD (@rahmioklu) 's Twitter Profile Photo

From IR lab Mayo Clinic Arizona IR, Congrats to post-doc Dr. Enes Cevik for this outstanding work! PVE, segmental ablation, drug delivery using a novel liquid embolic formulation. Phase 1 data was recently presented at SIR2024. Koç Üniversitesi Amerikan Hastanesi doi.org/10.1002/adma.2…

From IR lab <a href="/MayoClinicAZ_IR/">Mayo Clinic Arizona IR</a>, Congrats to post-doc Dr. Enes Cevik for this outstanding work! PVE, segmental ablation, drug delivery using a novel liquid embolic formulation. Phase 1 data was recently presented at SIR2024.  <a href="/kocuniversity/">Koç Üniversitesi</a> <a href="/vkv_amerikan/">Amerikan Hastanesi</a>   

doi.org/10.1002/adma.2…
Peter Pattison (@bsc_io) 's Twitter Profile Photo

Ready to learn more about #Obsidio #ConformableEmbolic? Join us July 27th for an in-person masterclass with expert faculty Kevin Henseler, MD, FACR and Rahmi Oklu, MD, PhD Rahmi Oklu MD, PhD. Spots are limited - secure yours soon! Register here: bit.ly/45EpCsP

Ready to learn more about #Obsidio #ConformableEmbolic? Join us July 27th for an in-person masterclass with expert faculty Kevin Henseler, MD, FACR and Rahmi Oklu, MD, PhD <a href="/rahmioklu/">Rahmi Oklu MD, PhD</a>. Spots are limited - secure yours soon! Register here: bit.ly/45EpCsP
Rahmi Oklu MD, PhD (@rahmioklu) 's Twitter Profile Photo

Just published! Great work to entire team! Prostate ablation for LUTS from BPH and prostate cancer! Direct needle injection into prostate for ablation takes min to do-no pain, no bleeding, no nerve injury, no incontinence! Phase2 trials very soon! Society of Interventional Radiology Mayo Clinic

Just published! Great work to entire team! Prostate ablation for LUTS from BPH and prostate cancer!  Direct needle injection into prostate for ablation takes min to do-no pain, no bleeding, no nerve injury, no incontinence! Phase2 trials very soon! <a href="/SIRspecialists/">Society of Interventional Radiology</a> <a href="/MayoClinic/">Mayo Clinic</a>
Science Translational Medicine (@sciencetm) 's Twitter Profile Photo

An injectable ionic liquid can safely ablate prostate tissue in large and small animals while delivering anticancer drugs to suppress tumor cells, supporting its utility as a safer therapy for #BenignProstateHyperplasia. Rahmi Oklu MD, PhD Mayo Clinic scim.ag/7zs

An injectable ionic liquid can safely ablate prostate tissue in large and small animals while delivering anticancer drugs to suppress tumor cells, supporting its utility as a safer therapy for #BenignProstateHyperplasia. <a href="/rahmioklu/">Rahmi Oklu MD, PhD</a> <a href="/MayoClinic/">Mayo Clinic</a> scim.ag/7zs
Rahmi Oklu MD, PhD (@rahmioklu) 's Twitter Profile Photo

Our work on next-gen chemoembolization is the cover article in Advanced Materials! With this approach, we show instant non-radioactive segmental embolization, uniform delivery of large therapeutics ie, Nivolumab, and targeted segmental/tumor ablation using the portal veins.

Our work on next-gen chemoembolization is the cover article in Advanced Materials!  With this approach, we show instant non-radioactive segmental embolization, uniform delivery of large therapeutics ie, Nivolumab, and targeted segmental/tumor ablation using the portal veins.